Rani Therapeutics Correlations

RANI Stock

USD 1.31 0.01 0.76%

The current 90-days correlation between Rani Therapeutics and Tenaya Therapeutics is 0.23 (i.e., Modest diversification). The correlation of Rani Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Rani Therapeutics Correlation With Market

Average diversification

The correlation between Rani Therapeutics Holdings and DJI is 0.12 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Rani Therapeutics Holdings and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rani Therapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Moving together with Rani Stock

0.75	ME	23Andme Holding	Pair Corr
0.72	VALN	Valneva SE ADR	Pair Corr
0.91	DNLI	Denali Therapeutics	Pair Corr
0.71	DNTH	Dianthus Therapeutics	Pair Corr
0.86	DOMH	Dominari Holdings	Pair Corr
0.8	DRRX	Durect	Pair Corr
0.94	DTIL	Precision BioSciences	Pair Corr
0.93	VIGL	Vigil Neuroscience	Pair Corr
0.88	VINC	Vincerx Pharma	Pair Corr
0.88	VKTX	Viking Therapeutics	Pair Corr
0.72	VRCA	Verrica Pharmaceuticals	Pair Corr
0.85	VRDN	Viridian Therapeutics Buyout Trend	Pair Corr
0.81	VRPX	Virpax Pharmaceuticals	Pair Corr
0.86	VRTX	Vertex Pharmaceuticals	Pair Corr

Moving against Rani Stock

0.89	DRTS	Alpha Tau Medical	Pair Corr
0.77	CDIOW	Cardio Diagnostics	Pair Corr
0.76	DMAC	DiaMedica Therapeutics	Pair Corr
0.72	VCEL	Vericel Corp Ord	Pair Corr
0.69	VCYT	Veracyte Potential Growth	Pair Corr
0.63	SABSW	SAB Biotherapeutics	Pair Corr
0.84	VRNA	Verona Pharma PLC	Pair Corr
0.79	DYAI	Dyadic International	Pair Corr
0.72	SRZNW	Surrozen Warrant	Pair Corr
0.63	VSTM	Verastem	Pair Corr
0.53	DVAX	Dynavax Technologies	Pair Corr
0.4	KTTAW	Pasithea Therapeutics	Pair Corr
0.36	VYNE	Vyne Therapeutics	Pair Corr

Related Correlations Analysis

	VINC	TNYA	CRVS	ALXO	LYRA	TRVI	SQZ	TARA	VCNX
VINC		0.01	0.56	-0.48	0.73	-0.49	0.72	-0.83	0.01	VINC
TNYA	0.01		0.65	-0.24	0.05	-0.68	0.51	-0.05	0.22	TNYA
CRVS	0.56	0.65		-0.66	0.47	-0.82	0.83	-0.6	0.03	CRVS
ALXO	-0.48	-0.24	-0.66		-0.19	0.59	-0.63	0.65	-0.1	ALXO
LYRA	0.73	0.05	0.47	-0.19		-0.32	0.44	-0.5	-0.32	LYRA
TRVI	-0.49	-0.68	-0.82	0.59	-0.32		-0.74	0.6	0.03	TRVI
SQZ	0.72	0.51	0.83	-0.63	0.44	-0.74		-0.69	0.23	SQZ
TARA	-0.83	-0.05	-0.6	0.65	-0.5	0.6	-0.69		0.11	TARA
VCNX	0.01	0.22	0.03	-0.1	-0.32	0.03	0.23	0.11		VCNX
	VINC	TNYA	CRVS	ALXO	LYRA	TRVI	SQZ	TARA	VCNX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

SQZ	+ 0.83	CRVS
LYRA	+ 0.73	VINC
SQZ	+ 0.72	VINC
CRVS	+ 0.65	TNYA
TARA	+ 0.65	ALXO
TARA	+ 0.6	TRVI

High negative correlations

TARA	- 0.83	VINC
TRVI	- 0.82	CRVS
SQZ	- 0.74	TRVI
TARA	- 0.69	SQZ
TRVI	- 0.68	TNYA
ALXO	- 0.66	CRVS

Risk-Adjusted Indicators

There is a big difference between Rani Stock performing well and Rani Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Rani Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
VINC	5.83	(0.99)	0.00	0.37	0.00	0.00	8.33	(10.34)	94.90
TNYA	6.94	0.30	0.03	0.10	10.62	(8.27)	18.44	(12.77)	75.41
CRVS	4.04	(0.25)	0.00	(0.35)	0.00	0.00	8.20	(8.82)	45.78
ALXO	4.74	0.38	0.06	(12.24)	5.97	(5.28)	15.43	(9.46)	35.80
LYRA	4.26	(0.01)	0.00	(0.02)	6.06	(6.71)	10.53	(10.00)	40.57
TRVI	3.82	0.46	0.11	(0.98)	3.41	(5.11)	6.59	(6.47)	52.36
SQZ	6.92	(1.95)	0.00	1.20	0.00	0.00	5.26	(23.08)	103.87
TARA	5.87	1.83	0.34	(20.05)	4.14	(8.04)	13.00	(7.16)	78.24
VCNX	7.68	(0.73)	0.00	(3.69)	0.00	0.00	12.36	(24.82)	85.55

Rani Therapeutics Corporate Management

Alireza Javadi	Vice Operations	Profile
Svai Sanford	Chief Officer	Profile
Mir Hashim	Chief Officer	Profile
Arvinder Dhalla	Vice Development	Profile
Bella Vazquez	Vice Resources	Profile
Eric Groen	General Counsel	Profile
Kate MBA	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC